Literature DB >> 3119723

A sensitive immunochemical assay for biologically active MuIFN-gamma.

R C Curry1, P A Kiener, G L Spitalny.   

Abstract

An immunochemical assay for the detection of mouse gamma interferon (MuIFN-gamma) has been established. Using a purified monoclonal antibody (MAb) that neutralizes the antiviral activity of MuIFN-gamma, and a polyclonal antibody (PAb) prepared against affinity-purified MuIFN-gamma, we have developed a double-sandwich enzyme-linked immunosorbent assay (ELISA). The assay is specific for both natural and recombinant MuIFN-gamma and displays only background activity against MuIFN-alpha + beta, recombinant TNF (rTNF), human gamma interferon (HuIFN-gamma) and crude rat spleen cell supernatants. The assay is more sensitive and reproducible than the measurement of hydrogen peroxide (H2O2) release by macrophages, and is capable of detecting both crude and purified MuIFN-gamma down to 0.03 U/ml of antiviral activity, making this assay 10-100 times more sensitive than the conventional antiviral assay. The ELISA detects only biologically active MuIFN-gamma since treatment of the MuIFN-gamma at high temperature or low pH conditions resulted in abolishment of biological activity, as determined by inhibition of cytopathic effect, coincident with a dramatic decrease in ELISA titer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119723     DOI: 10.1016/0022-1759(87)90497-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  39 in total

1.  Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum.

Authors:  P Zhou; M C Sieve; R P Tewari; R A Seder
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Evidence that endogenous gamma interferon is produced early in Listeria monocytogenes infection.

Authors:  A Nakane; A Numata; M Asano; M Kohanawa; Y Chen; T Minagawa
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.

Authors:  G S Nabors; J P Farrell
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus.

Authors:  V J La Posta; D D Auperin; R Kamin-Lewis; G A Cole
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement.

Authors:  T Tanaka; J Hu-Li; R A Seder; B Fazekas de St Groth; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.

Authors:  T M Scharton; P Scott
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

7.  Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice.

Authors:  H Perlmann; S Kumar; J M Vinetz; M Kullberg; L H Miller; P Perlmann
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice.

Authors:  W Chen; J A Harp; A G Harmsen; E A Havell
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.

Authors:  J K Actor; M Shirai; M C Kullberg; R M Buller; A Sher; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

10.  Cross-regulatory role of interferon-gamma (IFN-gamma), IL-4 and IL-10 in schistosome egg granuloma formation: in vivo regulation of Th activity and inflammation.

Authors:  S W Chensue; K S Warmington; J Ruth; P M Lincoln; S L Kunkel
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.